OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 71
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
ATP-binding cassette efflux transporters and MDR in cancer
Manasi S. Pote, Rajesh N. Gacche
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103537-103537
Open Access | Times Cited: 87
Manasi S. Pote, Rajesh N. Gacche
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103537-103537
Open Access | Times Cited: 87
A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk
Milad Ashrafizadeh, Wei Zhang, Rongjun Zou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106822-106822
Open Access | Times Cited: 63
Milad Ashrafizadeh, Wei Zhang, Rongjun Zou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106822-106822
Open Access | Times Cited: 63
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
Nauf Bou Antoun, Athina‐Myrto Chioni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12222-12222
Open Access | Times Cited: 39
Nauf Bou Antoun, Athina‐Myrto Chioni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12222-12222
Open Access | Times Cited: 39
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 27
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 27
m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway
Kai Lin, Endi Zhou, Ting Shi, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Kai Lin, Endi Zhou, Ting Shi, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism
Xia Li, Shuying Hu, Yaoting Cai, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 6
Xia Li, Shuying Hu, Yaoting Cai, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 6
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6
Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling
Zhijun Geng, Lugen Zuo, Jing Li, et al.
The FASEB Journal (2024) Vol. 38, Iss. 14
Open Access | Times Cited: 6
Zhijun Geng, Lugen Zuo, Jing Li, et al.
The FASEB Journal (2024) Vol. 38, Iss. 14
Open Access | Times Cited: 6
MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential
Fangying Dong, Jing Zhou, Yijie Wu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Fangying Dong, Jing Zhou, Yijie Wu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Chelidonine overcomes P-gp-mediated adriamycin resistance in MCF-7/ADR cells by inhibiting PDGFRβ/PI3K/Akt pathway
Xiang Zou, Yuhang Zhang, Kai‐Li Liu, et al.
Chinese Herbal Medicines (2025)
Open Access
Xiang Zou, Yuhang Zhang, Kai‐Li Liu, et al.
Chinese Herbal Medicines (2025)
Open Access
Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Kexin Yu, S Zhang, Jiali Shen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1362-1362
Open Access
Kexin Yu, S Zhang, Jiali Shen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1362-1362
Open Access
Exploring the effects of quercetin-added pancreatic diet on metabolic homeostasis in dogs via metabolomics
Xiaowan Liu, Yaohui Zhang, Xu Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318159-e0318159
Open Access
Xiaowan Liu, Yaohui Zhang, Xu Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318159-e0318159
Open Access
Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access
Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Overcoming drug resistance in ovarian cancer through PI3K/AKT signaling inhibitors
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene (2025), pp. 149352-149352
Closed Access
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene (2025), pp. 149352-149352
Closed Access
RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway
Tiantian Sheng, Hang Su, Yao Lu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Tiantian Sheng, Hang Su, Yao Lu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
José J.G. Marı́n, María J. Monte, Rocı́o I.R. Macı́as, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3524-3524
Open Access | Times Cited: 25
José J.G. Marı́n, María J. Monte, Rocı́o I.R. Macı́as, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3524-3524
Open Access | Times Cited: 25
Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present
Sarah Huff, Jordan M. Winter, Chris Dealwis
Biomolecules (2022) Vol. 12, Iss. 6, pp. 815-815
Open Access | Times Cited: 22
Sarah Huff, Jordan M. Winter, Chris Dealwis
Biomolecules (2022) Vol. 12, Iss. 6, pp. 815-815
Open Access | Times Cited: 22
Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
Milad Ashrafizadeh, Kuo Luo, Wei Zhang, et al.
Environmental Research (2023) Vol. 240, pp. 117443-117443
Closed Access | Times Cited: 14
Milad Ashrafizadeh, Kuo Luo, Wei Zhang, et al.
Environmental Research (2023) Vol. 240, pp. 117443-117443
Closed Access | Times Cited: 14
Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer
Ahmed I. Abulsoud, Shereen Saeid Elshaer, Nourhan M. Abdelmaksoud, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154855-154855
Open Access | Times Cited: 13
Ahmed I. Abulsoud, Shereen Saeid Elshaer, Nourhan M. Abdelmaksoud, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154855-154855
Open Access | Times Cited: 13
Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer
Lijie Zhou, Kaixuan Du, Yiheng Dai, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Lijie Zhou, Kaixuan Du, Yiheng Dai, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer
Zhe Yang, Feiran Chen, Dafu Wei, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Zhe Yang, Feiran Chen, Dafu Wei, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Terpenoids from quinoa reverse drug resistance of colon cancer by upregulating miR ‐495‐3p
Mangmang Feng, Xiaxia Fan, Jiangying Shi, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 14, pp. 8916-8927
Closed Access | Times Cited: 4
Mangmang Feng, Xiaxia Fan, Jiangying Shi, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 14, pp. 8916-8927
Closed Access | Times Cited: 4
Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Yuan Li, Caiming Xu, Haiyong Han, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 911-911
Open Access | Times Cited: 4
Yuan Li, Caiming Xu, Haiyong Han, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 911-911
Open Access | Times Cited: 4
